Cargando…

BRCA1 Protein Expression Level and CD44(+)Phenotype in Breast Cancer Patients

OBJECTIVE: CD44(+)/CD24(-/low) breast cancer cells have tumour-initiating properties with stem cell-like features. Breast cancer gene 1 (BRCA1) is a tumour suppressor gene that plays a crucial role in DNA repair and maintenance of chromosome stability. The clinicopatho- logical features of breast ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madjd, Zahra, Karimi, Adel, Molanae, Saadat, Asadi-Lari, Mohsen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Royan Institute 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584470/ https://www.ncbi.nlm.nih.gov/pubmed/23508738

Ejemplares similares

CD44 and CD24 cannot act as cancer stem cell markers in human lung adenocarcinoma cell line A549
por: Roudi, Raheleh, et al.
Publicado: (2013)

Oncogenic functions and clinical significances of DCLK1 isoforms in colorectal cancer: a systematic review and meta-analysis
por: Kalantari, Elham, et al.
Publicado: (2022)

Prediction of the treatment response in ovarian cancer: a ctDNA approach
por: Sharbatoghli, Mina, et al.
Publicado: (2020)

The CD44(+)/CD24(- )phenotype is enriched in basal-like breast tumors
por: Honeth, Gabriella, et al.
Publicado: (2008)

Brca1 breast tumors contain distinct CD44(+)/CD24(- )and CD133(+ )cells with cancer stem cell characteristics
por: Wright, Mollie H, et al.
Publicado: (2008)

The Association Between Higher Expression of Talin-1 and the Reduced Survival Rate in Ovarian Serous Carcinoma Patients
por: Sharbatoghli, Mina, et al.
Publicado: (2023)

A Systematic Review to Clarify the Prognostic Values of CD44 and CD44(+)CD24(-) Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead
por: Abdoli Shadbad, Mahdi, et al.
Publicado: (2021)

Do Clinical and Demographic Features of Patients with Upper-Gastrointestinal Cancer Affect their Health-related Quality of Life?
por: Esmaili-Hesari, Ramezan-Ali, et al.
Publicado: (2012)

Upregulation of Ganglioside GD2 Synthase (GD2S), as a New Putative Cancer Stem Cell Marker in Breast Carcinomas
por: Mansoori, Maryam, et al.
Publicado: (2021)

Correlation of Soluble CD44 Expression in Saliva and CD44 Protein in Oral Leukoplakia Tissues
por: Čēma, Ingrīda, et al.
Publicado: (2021)

CD44(+)/CD24(−) phenotype predicts a poor prognosis in triple-negative breast cancer
por: Wang, Hui, et al.
Publicado: (2017)

CD44 Variant Isoform Expression and Breast Cancer Prognosis
por: Tokue, Yutaka, et al.
Publicado: (1998)

Cobalt ferrite nanoparticle for the elimination of CD133+CD44(+) and CD44(+)CD24(−), in breast and skin cancer stem cells, using non-ionizing treatments
por: Khalili Najafabad, Bahareh, et al.
Publicado: (2023)

Copy Number Variation of Circulating Tumor DNA (ctDNA) Detected Using NIPT in Neoadjuvant Chemotherapy-Treated Ovarian Cancer Patients
por: Sharbatoghli, Mina, et al.
Publicado: (2022)

Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression
por: Rani, Bhavna, et al.
Publicado: (2018)

CD44s and CD44v6 Expression in Head and Neck Epithelia
por: Mack, Brigitte, et al.
Publicado: (2008)

Downregulation of CD44 reduces doxorubicin resistance of CD44(+)CD24(−) breast cancer cells
por: Van Phuc, Pham, et al.
Publicado: (2011)

SLUG/SNAI2 and Tumor Necrosis Factor Generate Breast Cells With CD44+/CD24- Phenotype
por: Bhat-Nakshatri, Poornima, et al.
Publicado: (2010)

Dynamic regulation of CD24 and the invasive, CD44(pos)CD24(neg )phenotype in breast cancer cell lines
por: Meyer, Matthew J, et al.
Publicado: (2009)

Selective killing of breast cancer cells expressing activated CD44 using CD44 ligand-coated nanoparticles in vitro and in vivo
por: Yang, Cuixia, et al.
Publicado: (2015)

CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients
por: Li, Zhonghu, et al.
Publicado: (2014)

The Role of CD44 and ERM Proteins in Expression and Functionality of P-glycoprotein in Breast Cancer Cells
por: Pokharel, Deep, et al.
Publicado: (2016)

CD44 activation state regulated by the CD44v10 isoform determines breast cancer proliferation
por: Guo, Qian, et al.
Publicado: (2021)

Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression Level
por: Klank, Rebecca L., et al.
Publicado: (2017)

A Study on Factors That Drive Variation in the Levels of Social Capital Among People Living With HIV/AIDS in Iran
por: Rimaz, Shahnaz, et al.
Publicado: (2015)

Immunodetection of cells with a CD44+/CD24- phenotype in canine mammary neoplasms
por: Magalhães, Geórgia Modé, et al.
Publicado: (2013)

Exosomal microRNAs as potential circulating biomarkers in gastrointestinal tract cancers: a systematic review protocol
por: Gheytanchi, Elmira, et al.
Publicado: (2017)

Differential expression of HIF-1α in CD44(+)CD24(-/low )breast ductal carcinomas
por: Oliveira-Costa, João Paulo, et al.
Publicado: (2011)

Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinoma
por: Sharbatoghli, Mina, et al.
Publicado: (2022)

The Phenotypic Radiation Resistance of CD44(+)/CD24(−or low) Breast Cancer Cells Is Mediated through the Enhanced Activation of ATM Signaling
por: Yin, Hong, et al.
Publicado: (2011)

Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity
por: Brown, Daniel V., et al.
Publicado: (2017)

Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes
por: Stefansson, Olafur Andri, et al.
Publicado: (2009)

Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells
Publicado: (1991)

The clinicopathologic association of c-MET overexpression in Iranian gastric carcinomas; an immunohistochemical study of tissue microarrays
por: Sotoudeh, Kambiz, et al.
Publicado: (2012)

The Expression of ERCC1, RRM1, and BRCA1 in Breast Cancer According to the Immunohistochemical Phenotypes
por: Kim, Dokyung, et al.
Publicado: (2011)

Activated mouse astrocytes and T cells express similar CD44 variants. Role of CD44 in astrocyte/T cell binding
Publicado: (1993)

The liberation of CD44
por: Cichy, Joanna, et al.
Publicado: (2003)

Clinicopathological Significance of Tumor Stem Cell Markers ALDH1 and CD133 in Colorectal Carcinoma
por: Rezaee, Maryam, et al.
Publicado: (2021)

CD44 Is Associated with the Aggressive Phenotype of Nasopharyngeal Carcinoma through Redox Regulation
por: Lin, Chien-Hung, et al.
Publicado: (2013)

The Expression and Prognostic Impact of CD95 Death Receptor and CD20, CD34 and CD44 Differentiation Markers in Pediatric Acute Lymphoblastic Leukemia
por: M. Kamazani, Fatemeh, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_sj7ki64n556snjlrfbn45490n6